PV pharm branch, vendor, cage 0U9U0
Ended Awarded
- Contract number
- SPE2D825FHW67
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $301,480
Award facts
- Contract value 100% obligated
- $301,480.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $301,480.48 from the Defense Logistics Agency's Medical Supply Chain on August 23, 2025. This competitively awarded, firm fixed-price contract with an ultimate completion date of August 25, 2025 represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract carries no set-aside designation, indicating it was awarded through open competition. The delivery order falls within AmerisourceBergen's existing SPE2DX IDC valued at $999,999,999.00 and running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
This delivery order exemplifies AmerisourceBergen's critical role as a federal medical procurement vendor, supplying pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates its capability to deliver a diverse range of medical commodities including brand-name and generic medications, vaccines, specialty pharmaceuticals, and medical devices across multiple therapeutic domains. The underlying IDC represents DLA's pharmaceutical prime vendor strategy, which is designed to ensure reliable supply chains for military medical operations globally while leveraging competitive contracting mechanisms to optimize cost and service delivery.
Quick answers
Who was awarded contract SPE2D825FHW67?
SPE2D825FHW67 was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on August 23, 2025.
How much is contract SPE2D825FHW67 worth?
The government has obligated $301,480 on SPE2D825FHW67.
Is contract SPE2D825FHW67 an order under another contract?
Yes. SPE2D825FHW67 is a delivery order under SPE2DX22D0010, an indefinite delivery contract.
Was contract SPE2D825FHW67 competed?
The extent of competition for SPE2D825FHW67 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award